parthenolide and B-Cell Chronic Lymphocytic Leukemia

parthenolide has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Duke, VM; Ganeshaguru, K; Hoffbrand, AV; Jones, DT; Kottaridis, PD; Lowdell, MW; Mehta, AB; North, JM; Prentice, AG; Steele, AJ; Wickremasinghe, RG; Yogashangary, BC	1

Other Studies

1 other study(ies) available for parthenolide and B-Cell Chronic Lymphocytic Leukemia

Article	Year
The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia, 2006, Volume: 20, Issue:6 Topics: Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hematopoietic Stem Cells; Humans; Lactones; Leukemia, Lymphocytic, Chronic, B-Cell; Mitochondria; NF-kappa B; Sesquiterpenes; T-Lymphocytes; Tumor Suppressor Protein p53; Up-Regulation	2006

Article

Year

The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro.

Leukemia, 2006, Volume: 20, Issue:6

Topics: Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hematopoietic Stem Cells; Humans; Lactones; Leukemia, Lymphocytic, Chronic, B-Cell; Mitochondria; NF-kappa B; Sesquiterpenes; T-Lymphocytes; Tumor Suppressor Protein p53; Up-Regulation

2006